Reaction
Ketosis reporting signals
As of the last recalculation, Ketosis appears in 1,018 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is DAPAGLIFLOZIN (PRR 143.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dapagliflozin | 182 | 143.8 | 144.7 |
| Empagliflozin | 144 | 50.8 | 50.9 |
| Insulin Glulisine | 13 | 26.5 | 26.5 |
| Canagliflozin | 37 | 26.2 | 26.2 |
| Insulin Glargine-Yfgn | 24 | 23.0 | 23.0 |
| Metformin Hydrochloride Tablets | 50 | 18.7 | 18.7 |
| Metformin Hydrochloride Extended-Release Tablets | 50 | 18.7 | 18.7 |
| Metformin Hydrochloride Tablet | 50 | 18.7 | 18.7 |
| Metformin Hydrochloride | 50 | 18.1 | 18.1 |
| Insulin Degludec | 19 | 16.8 | 16.9 |
| Oxazepam | 16 | 15.4 | 15.5 |
| Clobazam | 17 | 14.5 | 14.5 |
| Levetiracetam In Sodium Chloride | 48 | 13.2 | 13.3 |
| Levetiracetam Oral | 48 | 13.2 | 13.3 |
| Levetiracetam Injection | 48 | 13.2 | 13.2 |
| Pitavastatin Calcium | 6 | 12.1 | 12.1 |
| Insulin Lispro | 60 | 9.4 | 9.4 |
| Liraglutide | 21 | 8.9 | 8.9 |
| Oral Semaglutide | 26 | 7.4 | 7.4 |
| Dulaglutide | 25 | 5.9 | 5.9 |
| Tirzepatide | 38 | 5.0 | 5.0 |